Sumit Isharwal

848 total citations
13 papers, 359 citations indexed

About

Sumit Isharwal is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sumit Isharwal has authored 13 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sumit Isharwal's work include Bladder and Urothelial Cancer Treatments (8 papers), Urinary and Genital Oncology Studies (4 papers) and Epigenetics and DNA Methylation (4 papers). Sumit Isharwal is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Urinary and Genital Oncology Studies (4 papers) and Epigenetics and DNA Methylation (4 papers). Sumit Isharwal collaborates with scholars based in United States, United Kingdom and Netherlands. Sumit Isharwal's co-authors include Hikmat Al‐Ahmadie, Gopa Iyer, Bernard H. Bochner, David B. Solit, Dean F. Bajorin, Michael F. Berger, Jonathan E. Rosenberg, Guido Dalbagni, K. Eugene and Eugene J. Pietzak and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Urology.

In The Last Decade

Sumit Isharwal

12 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumit Isharwal United States	4	295	146	83	69	39	13	359
Quoc Cuong Tran Australia	5	185 0.6×	134 0.9×	53 0.6×	105 1.5×	31 0.8×	6	290
Abimbola Ayangbesan United States	4	151 0.5×	114 0.8×	49 0.6×	52 0.8×	10 0.3×	10	286
Nicolás Chesa Spain	5	162 0.5×	92 0.6×	66 0.8×	38 0.6×	19 0.5×	5	270
Katie Gustafson United States	4	226 0.8×	101 0.7×	41 0.5×	56 0.8×	49 1.3×	5	294
Yongli Chang China	6	240 0.8×	132 0.9×	33 0.4×	37 0.5×	18 0.5×	9	368
Lisa M.C. van Hoogstraten Netherlands	6	138 0.5×	59 0.4×	36 0.4×	60 0.9×	27 0.7×	14	224
Kirstin A. van der Keur Netherlands	6	329 1.1×	176 1.2×	81 1.0×	43 0.6×	59 1.5×	7	388
Petter Kollberg Sweden	8	292 1.0×	66 0.5×	81 1.0×	72 1.0×	14 0.4×	16	312
Susumu Tanji Japan	10	57 0.2×	66 0.5×	79 1.0×	44 0.6×	14 0.4×	36	246
Akhmad Makhmudi Indonesia	12	261 0.9×	36 0.2×	36 0.4×	27 0.4×	33 0.8×	34	316

Countries citing papers authored by Sumit Isharwal

Since Specialization

Citations

This map shows the geographic impact of Sumit Isharwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Isharwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Isharwal more than expected).

Fields of papers citing papers by Sumit Isharwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumit Isharwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Isharwal. The network helps show where Sumit Isharwal may publish in the future.

Co-authorship network of co-authors of Sumit Isharwal

This figure shows the co-authorship network connecting the top 25 collaborators of Sumit Isharwal. A scholar is included among the top collaborators of Sumit Isharwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumit Isharwal. Sumit Isharwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Aaronson, Neil K., Mirjam A. G. Sprangers, Peter Fayers, et al.. (2019). Inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) with elderly cancer patients: A systematic review.. Journal of Clinical Oncology. 37(15_suppl). e18217–e18217. 1 indexed citations

Aaronson, Neil K., Mirjam A. G. Sprangers, Peter Fayers, et al.. (2019). Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and over time? A pooled analysis of 610 RCTs published between 2004 and 2018.. Journal of Clinical Oncology. 37(15_suppl). e18218–e18218. 1 indexed citations

Isharwal, Sumit, Wenhuo Hu, Judy Sarungbam, et al.. (2019). Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. The Journal of Pathology. 248(3). 260–265. 30 indexed citations

Wong, Nathan C., Shawn Dason, Sumit Isharwal, et al.. (2019). Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT).. Journal of Clinical Oncology. 37(7_suppl). 531–531. 1 indexed citations

Isharwal, Sumit, Gouri J. Nanjangud, François Audenet, et al.. (2018). Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma. Human Pathology. 77. 63–69. 32 indexed citations

Isharwal, Sumit, François Audenet, Esther Drill, et al.. (2018). MP54-04 NEXT GENERATION SEQUENCING OF UROTHELIAL BLADDER CANCER: MEMORIAL SLOAN KETTERING CANCER CENTER EXPERIENCE IN 454 PATIENTS. The Journal of Urology. 199(4S).

Isharwal, Sumit, François Audenet, Esther Drill, et al.. (2018). Next generation sequencing of urothelial bladder cancer: Memorial Sloan Kettering Cancer Center experience in 454 patients.. Journal of Clinical Oncology. 36(6_suppl). 469–469. 2 indexed citations

Dason, Shawn, Victor McPherson, Min Yuen Teo, et al.. (2018). Defining the DNA damage repair (DDR) genomic landscape of urothelial carcinoma of the bladder (UCB).. Journal of Clinical Oncology. 36(6_suppl). 502–502. 3 indexed citations

Pietzak, Eugene J., Aditya Bagrodia, K. Eugene, et al.. (2017). Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. European Urology. 72(6). 952–959. 258 indexed citations

10.

Isharwal, Sumit, Hongying Huang, Gouri J. Nanjangud, et al.. (2017). Intratumoral heterogeneity of ERBB2/HER2 expression in micropapillary urothelial carcinoma.. Journal of Clinical Oncology. 35(6_suppl). 383–383. 1 indexed citations

11.

Audenet, François, Sumit Isharwal, Maria E. Arcila, et al.. (2017). Targeting ERBB2 mutations in urothelial carcinoma.. Journal of Clinical Oncology. 35(6_suppl). 354–354. 2 indexed citations

12.

Audenet, François, Mark T.A. Donoghue, Eugene J. Pietzak, et al.. (2017). Genomic comparison of matched primary and metastatic germ cell tumors (GCT).. Journal of Clinical Oncology. 35(15_suppl). 4556–4556. 1 indexed citations

13.

Isharwal, Sumit, Shipra Arya, Anoop Misra, et al.. (2008). Dietary Nutrients and Insulin Resistance in Urban Asian Indian Adolescents and Young Adults. Annals of Nutrition and Metabolism. 52(2). 145–151. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact